432 filings
Page 14 of 22
6-K
7zrba4
27 May 16
As Representative of the Underwriters named on Schedule 1 attached hereto 1 North Federal Highway, 5th Floor
12:00am
424B5
aww eejzrayh4
27 May 16
Prospectus supplement for primary offering
12:00am
424B5
pcy7nku
26 May 16
Prospectus supplement for primary offering
12:00am
6-K
i5ryuexgnf32qeg53px
26 May 16
Intellipharmaceutics Announces Proposed Public Offering of Units of Common Shares and Warrants
12:00am
6-K
xdae40f0lft uezmsz
20 Apr 16
Intellipharmaceutics Reports Director Election Results
12:00am
6-K
wtf0532qb8dpcqrfc7h7
15 Apr 16
Current report (foreign)
12:00am
6-K
6hfub8sl9nzi3gbkmvph
18 Mar 16
Annual & Special Meeting of Shareholders
12:00am
6-K
7ef5xdtde5gjf0
15 Mar 16
Current report (foreign)
12:00am
6-K
umkxe 23p
9 Mar 16
Intellipharmaceutics to Present at the28th Annual ROTH Conference
12:00am
6-K
peonvuz7cp 973huv4w
1 Mar 16
Current report (foreign)
12:00am
6-K
g85axwp36umes75j
29 Feb 16
Current report (foreign)
12:00am
6-K
bunj8 6jkkh
25 Feb 16
Current report (foreign)
12:00am
6-K
wr28466b
19 Jan 16
Intellipharmaceutics to Present at the Noble Financial Capital Markets’ 12th Annual Investor Conference
12:00am
6-K
4ejw gu8cuqw
14 Jan 16
Intellipharmaceutics Announces Successful Bioequivalence Results for Abuse Deterrent Rexista™ Oxycodone XR
12:00am
6-K
l9bs4
21 Dec 15
Intellipharmaceutics to Present at the Biotech ShowcaseTM
12:00am
6-K
dmxv 8chdm4p
24 Nov 15
Intellipharmaceutics to Present at the LD Micro Main Event
12:00am
6-K
56hyi81e
27 Oct 15
Intellipharmaceutics to Present at The MicroCap Conference
12:00am
6-K
t9nof1qe ribixn4po4e
15 Oct 15
Current report (foreign)
12:00am
6-K
25xws7
9 Oct 15
Intellipharmaceutics to Present at Dawson James Securities Growth Stock Conference
12:00am